WASHINGTON, Feb. 23, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.21 per share of its common stock, payable on April 30, 2021 to holders of record on March 26, 2021. In addition, the Board of Directors has approved a quarterly cash... Read more
Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 23, 2021– PerkinElmer, Inc. (NYSE: PKI) today announced the launch of the PerkinElmer® COVID-19 Antigen Test for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in nasal (NS) or nasopharyngeal (NP) swab specimens. The lateral flow... Read more
Thermo Fisher Scientific Announces Oncomine Clinical Research Grant 2021 Call for Submissions CARLSBAD, Calif., Feb. 23, 2021 /PRNewswire/ — Thermo Fisher Scientific has opened a call for submissions for its Oncomine Clinical Research Grant program to support clinical research. The program aims to assist educational and independent research projects that exhibit excellence in molecular profiling... Read more
February 17, 2021, Peabody, Mass. – JEOL builds upon its legacy of successful AccuTOF™ GC series gas chromatograph – time-of-flight mass spectrometers with the release of the JMS-T2000GC “AccuTOF™ GC-Alpha”. This product is a GC-MS that represents significant improvement in performance and functionality using two newly developed key technologies. The basic hardware performance has been greatly improved... Read more
February 22, 2021 The Novel Coronavirus Detection Kit for Wipe Tests Shimadzu Corporation has released the Novel Coronavirus Detection Kit for Wipe Tests. This reagent kit detects the novel coronavirus on surfaces quickly, easily, and with high sensitivity via the PCR test method. It is intended for use in hygiene management and health and safety... Read more
Companion diagnostic can help guide treatment decisions in cases of NSCLC SANTA CLARA, Calif., February 22, 2021 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s PD-L1 IHC 22C3 pharmDx assay for expanded use in patients with non-small cell lung cancer (NSCLC). PD-L1 IHC 22C3... Read more
WASHINGTON, Feb. 22, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Cowen Healthcare Conference on Monday, March 1, 2021 at 11:40 a.m. ET. The video will be simultaneously webcast on www.danaher.com. ABOUT DANAHERDanaher is a global science and technology innovator committed... Read more
Venlo, the Netherlands, February 22, 2021 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today the appointment of Thomas Ebeling, a leading international executive with extensive experience in the healthcare, media and consumer goods industries, as a member of the Supervisory Board with immediate effect. Mr. Ebeling joins QIAGEN as part of a process... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 22, 2021– PerkinElmer, Inc., (NYSE: PKI) a global leader committed to innovating for a healthier world, today provided an update on the COVID-19 Valencia Branch Laboratory’s (VBL) accreditation process. The VBL is operated by PerkinElmer in partnership with the California Department of Public Health (CDPH). The VBL started operations on November 1,... Read more
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the following virtual conferences: 10th Annual SVB Leerink Healthcare Conference Thursday, February 25, 2021, at 8:40 a.m. Eastern TimeFrank Laukien, Chairman, President and Chief Executive Officer Cowen 41st Annual Health Care Conference Tuesday, March 2, 2021, at 11:10 a.m. Eastern TimeGerald Herman,... Read more